The clinical spectrum of SSPE
There are 2 forms of encephalitis following measles infection. The first is the relatively common acute post infections measles encephalitis which develops in about 0.1 percent of immunocompetent patients and carries a 20 percent mortality rate. This form of encephalitis is not caused by direct invasion of the brain by MV. Indeed, only with highly sensitive methods could MV specific nucleic acids be detected in the brains of patients with this form of encephalitis. Those findings are in line with the assumption that this is a true example of measles virus induced pathological immune mediated "post-infectious" encephalitis. In contras, MV is present in the brains of the immunocompetent patients and causes SSPE while in immunocompromized patients it causes Measles Inclusion Body Encephalitis. Both conditions are fatal and present clinically months or years after the initial measles infection. The clinical presentation of SSPE is often insidious and frequently attributed to psychological or behavioural problems. The exception to this are those cases who present acutely with focal neurological signs and progress rapidly to coma and death.
The following case report represents the protracted and peculiar clinical course of SSPE
Case report 2
This 16 year old girl was born in 1963 to healthy Jewish parents who immigrated to Israel from Morocco in 1949. Her past medical and developmental history was unremarkable. There was no history of clinical measles or an exanthematous early febrile illness. She received measles immunization soon after it was initiated in Israel during 1967. At the age of 7 years, during the second elementary school year, an unexplained decline in her school performance was noted. A paediatric neurological assessment was summarized as Attention Deficit Disorder for which supplementary teaching and Methylphenidate (Ritalin R ) 10 mg daily was prescribed. An EEG showed right sides periodic delta wave discharges and for that brain CT with contract enhancement was done and read normal. The EEG findings were attributed to "sweating artefact".The clinical course was stable for 18 months during which a slow deterioration was noticed in her general alertness and vigilance according to the mother. This was however denied by her school teachers who thought that she did quite well in school and received excellent school reports. The anxious mother consulted several child neurologists and psychiatrists who failed to find any abnormalities. A repeated EEG showed generalized periodic slow delta bursts with slow background activity. Serum and CSF measles antibody titers by complement fixation were 1: 256 and 1:32 respectively. A diagnosis of SSPE was considered for which daily Isoprinosine and several courses of intravenous "Thymic Humoral Factor" (THF), were given as part of 2 experimental treatment trials which were at that time done in Israel. That was followed by clinical improvement in her vigilance. She enjoyed the routine daily life of a young girl until the age of 11 years when frequent falls, schoolwork deterioration and sudden brief neck and back flexion movements associated with the falls were noted. She started to behave "strangely", and had difficulties in recognition of familiar faces and objects. When examined by me for the first time she had marked visual agnosia and neck and axial myoclonus. Her EEG showed additional background slowing with "metronomic" delta bursts resembling "Burst Suppression" pattern. Clonazepam (clonex R ) was helpful only for a short period of time. Both serum and CSF measles antibody titers, and brain CT were almost unchanged. Her condition gradually deteriorated. She spent her last 2 years of life in a nursing home during which continuous very high fever unresponsive to a variety of antipyretics, bouts of sweating accompanied by brady-tachy arrhythmia, and generalized rigidity were present. Her EEG was almost isoelectirc without evidence of periodic bursts during the last weeks of her life. She died of aspiration pneumonia. Autopsy was not permitted for religious reasons. Those 2 cases represent the wide spectrum of the clinical features and course of SSPE and also the difficulties of considering SSPE in the differential diagnosis at the early stags of the disease, a fact which explains the delay in the diagnosis in some cases. 
Characteristic clinical features
The majority of the patients the initial symptoms are noted between the ages of 8-11 years, about 6-7 years after measles infection. Zilber et al. initiated a country survey of SSPE in Israel by obtaining information from the Israeli National Neurological Diseases Register (INNDR), the Central Virus Laboratory which at that time tested sera and CSF for measles antibodies throughout the country and the medical records of patients diagnosed with SSPE from all hospitals in the country between the years 1960 -1973 (Zilebr at al., 1983 . Hundred and eight such patients were detected, 40 of them were followed by the author of this chapter. The onset of SSPE accrued during 1968-1979. The mean age of onset was almost identical to that reported for children in USA (9.5 y.) and UK (9.8 y.). The interval (in years) between clinical measles and onset of SSPE in the Israeli children (7.4 y.), was also similar to that of USA and UK children (7.0 and 6.8 y. respectively). However, the interval (in years) between the time of measles vaccination and SSPE varied between 6.5 years in Israel, and 3.3 and 3.0 in the USA and UK respectively. All Israeli children with SSPE had progressive neurobehavioral deterioration, myoclonic jerks and characteristic EEG. Sixty eight percent had elevated serum measles antibodies and 89% had increased titer of those antibodies in the CSF. A quite surprising finding was the low percentage of patients (13%) with brain pathology characteristic of SSPE. True epileptic seizures were a rarity. We have seen only 6 out of our cohort of 40 patients who had true epileptic seizures. Those were 5 boys and 1 girl who had a similar age of onset and disease features. The mean interval between SSPE onset and the first seizure was 15 months (3 -24). The EEG was mostly focal and the response to Anti Convulsive Drugs (ACD) varied from excellent in 2 patients, good in one and poor in 2. One patient who failed to respond to ACD was given a ketogenic diet which was beneficial. The common denominator of these patients was antecedent neurological impairment. Four suffered from viral encephalitis at one year of age, one had severe learning problems diagnosed prior to the onset of SSPE and the sixth had severe congenital sensory-neural deafness. Two similar cases have been recently reported (Demir et al., 2009 ). In few patients focal seizures in the form of epilepsia partialis continua and an EEG showing Periodic Lateralizing Epileptic Discharges (PLED) were reported. This pattern was associated with a fulminant course (Santoshkumar & Radhakrishnan 1996 , Cherian et al., 2009 ). As mentioned above, earlier publications indicated that epileptic seizures are rare and appear at late stages of the disease. More recent publications such as the paper by Kissani (Kissani et al., 2001) , indicate that epilepsy is rather frequent. In a series of 70 patients with SSPE from Morocco, 30 had true epileptic seizures.In two-thirds of them the seizures started during the first year of the disease and in 23%, were the presenting symptom. Partial seizures with secondary generalization were most common in the very early stages of the disease and frequently led to the correct diagnosis. When seizures appeared late in the course of the disease (43%), they were mainly generalized tonic-clonic (GTCS). The "heralding" partial seizures are most probably indicators of focal onset of encephalitis with generalized spread later on. The diagnosis of SSPE is quite straight forward and easily reached in children if the attending paediatricians and child neurologists are familiar with the disease. This is quite different when the disease affects adults. The occurrence of SSPE in subjects older than 18 years is quite rare, comprising 1-12.7% of all patients (Prashanth et al., 2006) . Adult onset SSPE presents at an average age of 25 years and rarely follows the classical clinical stages mentioned above. Visual symptoms at presentation are frequent (Singer et al., 1997) , while myoclonus may be absent. About 30 % of 52 such patients lacked a history of measles (Fabian et al., 2010) .
Electroencephalographic and neuroimaging features
The most characteristic EEG feature is the periodic, stereotyped, high voltage discharges which appear concomitantly with the appearance of the myoclonic jerks. At early stages of the disease, the EEG may be normal or show moderate non-specific generalized slowing. As the diseases progresses, the periodic discharge pattern emerges, at first only during sleep, before myoclonic jerks are evident. In early stages, administration of IV diazepam can bring out the typical bursts. Somewhat later in the course and concomitantly with the appearance of typical myoclonus, the characteristic periodic discharge pattern can be seen also during wakefulness. This pattern consists of bilateral synchronous symmetrical bursts with an amplitude of 200-500 mV. Each burst consists of polyphasic, monomorphic delta waves. The bursts appear every 4-10 seconds with an identical morphology in any recording lead and are rhythmic ("metronomic"). The bursts are "time locked" with the myoclonic jerks. The interval between the bursts becomes shorter with disease progression. In advanced stages this pattern is replaced by disorganized slow delta rhythm. The voltage of the recording gets smaller and at stage IV it may became almost iso-electric ( Figure. 2) In a relatively recent study from India (Praveen-Kumar et al., 2007) , the EEG features of 58 patients with SSPE (stage I: 10.2%; II: 64%; III: 25.8%), were analyzed and related to the stage of disease and neuroimaging findings. Bursts as defined above were found in 98% of the patients. Those were periodic in 55%, "quasi-periodic" in 36% and non-periodic in 6%. The periodic bursts were asymmetrical in 33%. The burst morphology, frequency and inter-burst interval were not influenced by hyperventilation, photic or sensory stimulation. Normal background was recorded in all patients in stage I, and slow background in all other stages. Spike and sharp wave epileptiform discharges were present in 72.4% of the patients. Those were mostly generalized and only in 10 patients epileptiform activity was lateralized or multifocal. The focal discharges were mostly fronto-parietal. Periodic Lateralizing Epileptic Discharges (PLED's), were present in 10 recordings. Asymmetry of background activity or bursts were associated with lateralizing neurological deficits. However, there was no correlation between the EEG asymmetry and CT or MRI findings. Brain neuroimaging was performed in 44 patients and both CT and MRI in 11 patients only. The main neuro-imaging findings consisted of brain oedema and atrophy seen in all stages of the disease while signal intensity changes were present in stages II-III. Parieto-occipital white matter was affected in stage II while diffuse fronto-parteital changes were more common in stage II-III. There was no contrast enhancement by Iodine or Gadolinium. Although there was no correlation between the imaging features and focal EEG changes or the abnormal neurological findings, a significant association between visual deficits and parieto-occipital signal changes on MRI was found. In a more recent study (Aydin et al., 2009 ), 17 patients with SSPE who had a routine normal MRI and 30 healthy matched controls underwent T1-weighted magnetization-prepared rapid acquisition gradient echo images. When optimized method of voxel-based morphometry performed across-sectional analysis were applied to search for gray matter volume differences between the patients and controls, a fronto-temporal reduction of the cortical gray matter was found in the patients,regardless of the duration of symptoms or the presence and nature of neurological deficits.
Neuropathology
In the early phase of the disease brain oedema with DNA and RNA oxidative damage within infected cells are the typical findings. There is evidence of lipid peroxidation in areas of early demyelination (Hayashi et al., 2002) . The main histopathological findings in the acute phase are inflammatory and consist of the classical cortical and subcortical "perivascular cuffing", spongiosis and demyelination, sparing the cerebellum (Figure 3) . Initially, posterior brain regions are the most affected. Pronounced changes are seen in the medial thalamus and the deep structures. With disease progression more anterior areas, brain stem and spinal cord are also affected. The inflammatory cellular response consists of focal and/or diffuse perivascular infiltrates of lymphocytes, plasma cells and phagocytes which are present within brain parenchyma as well as in the menings. The astrocytes, oligodendrocytes and microvascular endothelium are the mostly infected cell types (Allen et al., 1996) .The nuclear and cytoplasmic inclusion bodies seen in neurons and oligodendrocytes are Cowdry type-A inclusions which contain homogeneous eosinophilic material. They are diffusely distributed mostly in the fulminant cases while the small multiple Cowdry type-B inclusion bodies, are almost always present in the brainstem. The nuclear inclusions correspond to measles viral particles and contain viral antigens. Neurofibrillary tangles may be present within neurons and oligodendrocytes. The tangles contain viral genome as shown by in-situ hybridization. Those findings suggest that the tangles are the result of the viral infection. (McQuaid et al., 1994) . The inflammatory reaction and even the inclusion bodies are typical for the early stages of the disease and are hard to find at the later stages. Typically for SSPE as a model for slow virus infection, it is very difficult to isolate even a small amount of infectious virus from the brain while viral antigens can be quite easily identified.
Immunopathology
A large number of major histocompatibility complex (MHC) class I-II positive cells were seen by immunohistochemical methods in SSPE brains, especially in a perivascular distribution. By morphological criteria, HLA -DR positive microglia and reactive astrocytes were also identified. (Hofman et al., 1991) . Although cell mediated immunity was found to be abnormal in a small series of patients such as our own where 11/15 patients had some evidence of such an impairment (Handzel et al.,1983) , no specific immune defect was found in SSPE (Schneider-Schaulies et al., 2003) . The inflammatory perivascular cell infiltrates are predominantly CD4+ T cells, while B cells are seen more frequently in parenchymal inflammatory infiltrates. We have shown in 11 patients with SSPE, that similar to matched controls, they had no detectable plasma interferon (INF) activity. However, their PBMC failed to produce INF following stimulation with polyinosinic:polycytidilic acid (poly I:C and Phytohemagglutinin (PHA) (Gadoth et al., 1989) 
Pathophysiology
One of the prevailing theories suggests that in spite of the lack of evidence for a specific immune defect causing SSPE, impaired immune response plays an important role in its pathophysiology. The observation that early infection with MV virus at the time when the immune system is relatively immature, is associated with increased risk for SSPE (Tuxhorn, 2004) , was a pivotal step in understanding the disease. Normally, during the incubation phase of measles, the invading virus induces a cell mediated immune response with activation of T-Helper 1 (Th1) lymphocytes, release of INF-α, and interleukin 2 (IL-2), which is capable of eradicating the invading virus particles from the infected cells. Following the characteristic measles papulo-macular skin rash, a humoral antibody mediated long term immunity against future infection is established via the production of Th2 lymphocytes, release of mainly IL-4 and to a lesser extent INF-α and IL-2. (Griffin et al., 1994) . Due to genetic polymorphism, patients with SSPE have an inadequate cellular immune responses to common antigens and produce markedly decreased amounts of IFN (Handzel et al., 1983) , and IL -2,10,12, while producing increased amounts of IL -4 and IL-1b. (Yentür et al., 2005) . The induction of this set of humoral immune responses in patients with SSPE rather than producing a cellular immune response which is capable of completely eradicate the MV from the infected cells, is believed to play a major role in the pathogenesis of the disease and contributes to the ability of the mutated measles virus to persist in a dormant form within the brain. (Inoue et al., 2002) . The variable incidence rates of SSPE in different populations and ethnic groups can be partially attributed to genetic polymorphism in addition to a number of epidemiological variables which will be discussed below. Measles virus uses the cluster of differentiation (CD) protein 46 and fusion protein (protein F), to invade the neuron. The fact that high antibody titers to CD9 were detected in CSF of patients with SSPE who had severe brain atrophy, indicates that this protein plays also a role in neuronal invasion of the virus (Shimizu et al., 2002) . After entering the cell the viral matrix protein undergoes mutations and cannot be recognized by the immune system. This is followed by virus replication and persistence within the infected cell without being eradicated by the immune system (Makhortova et al., 2007) . In addition, a truncated protein F receptor may also play a causative role. Neurokinin-1 is implicated in the spread of the mutated virus to adjacent cells. After a variable period when the virus is dormant, it induces an inflammatory immune mediated reaction directed against the infected cells, which results in widespread CNS damage. Those mentioned immune mechanisms may also play a role in other chronic demyelinating CNS disorders. The patients were then given oral Isoprinosine for several days which resulted in significant elevation of serum INF and corrected the failure of INF production by the similarly stimulated PBMC. Moreover, 10 days after discontinuation of the drug, the INF system returned to its inactive state. Several patients were treated for extended periods of time with a 20% remission rate and or 4 year survival. (Gadoth et al., 1989) . Other investigators have shown a beneficial effect of the drug in up to 30-35% of the patients which is significantly higher than the reported 5% spontaneous remission rate (Dyken et al., 1982) . Other agents such as Ribavirin, which blocks RNA polymerase without and in combination with INF, Anti CD2O antibodies, THF, Amantadine, Steroids and plasmapehresis showed some beneficial effect in selected non-randomized trials. Several patients have been treated with intraventricular INF-α alone or in combination with oral Isoprinosine but with no advantage over the intrathecal route (Yalaz et al., 1992) .
Treatment

Epidemiology
The dramatic changes in the epidemiology of SSPE in relation to the world-wide immunization project against measles are fascinating. The reduction in measles incidence especially in immunized infants was followed by a dramatic fall in the rate of SSPE in the developed countries of the western hemisphere and in other world regions where measles immunization became mandatory. In addition, some changes occurred in the previously described "classical" characteristics of the disease such as the age of onset and a number of clinical features. In a relatively recent world wide review of the rate of measles and SSPE before and after the institution of measles immunization, the dramatic drop in the incidence of SSPE due to immunization was clearly shown (Campbell et al., 2007) . Israel served and still serves as a good site for classical epidemiological studies because of its heterogenic ethnic population, high standard of medical care and a well organized medical and health system which enables the particular researcher to obtain well documented data throughout the country. For this reason data from Israel can provide an excellent example of the role of mass measles immunization on the rate of SSPE. The country has a wide-spread network of Mother and Child health clinics which serve the entire county's population. The individual clinics keep careful records of each child's immunization program, and the medical staff is alert to those who fail to show for their clinic visits or to the immunization schedule, established by the Israeli Ministry of health. Due to the nominal cost of those services, it can be assumed that the diagnosis and reports of patients with SSPE are accurate and most probably complete. Population studies of SSPE were carried out in Israel since 1960, while mass measles vaccination was introduced in 1967. Thus, most of the children born after February 1965 were immunized. Considering the standard of medical care in Israel and the size of its population in 1975 (3.5 million), it can be assumed that a rare disease such as SSPE was reported in sufficient numbers during those years when the local and world wide SSPE "epidemic" suddenly emerged. All those factors enabled an accurate analysis of SSPE incidence in regard to a number of variables including the role of mass immunization against measles. Zilber (Zilber et al., 1983) , obtained data on SSPE rates from the Israeli National Neurological Disease Register which received notification on all neurological disorders recorded in all hospitalized patients around the country. Death certifications with a code for any neurological disorder were also retrieved. Assuming that the varied and dramatic symptoms of SSPE will eventually lead to hospitalization of the affected child, it is highly likely that the register was notified of almost all patients with SSPE during the period of this study which covered the period of 1968-1979. The medical records of all detected cases were obtained. As the register was notified also on cases of measles encephalitis, non-specific encephalitis, and degenerative progressive neurological diseases in children, the charts of such cases were also obtained and reviewed for possible SSPE. The records from the central virology laboratory which performed serum and CSF measles antibody titers for the entire country since 1968 until the publication of the mentioned study were searched for tests with increased measles antibody titers and the patients details and medical records were obtained. In a previous study by the same group (Soffer et al., 1975) the medical records of patients with the diagnosis of SSPE from all Israeli hospitals for the period of 1960-1973 were reviewed. In addition, the departments of paediatrics, neurology and the EEG laboratories across the country were asked to provide information on additional patients. The multi-source information thus gathered enabled to exclude multiple reports of the same patient and provided a high level of ascertainment of the data obtained. The main findings of this study confirmed the presence of a steep drop in incidence of SSPE in vaccinated Israeli children noted mainly in 1977, 10 years after the initiation of mass immunization. The rate of SSPE remained low at the completion of this study in 1979. The calculated rate of SSPE (per 10 6 live births) during the period of 1965-1971 was 246 in non vaccinated patients compared to 27 in vaccinated subjects. The rate of 27 included patients who developed measles after immunization. When those patients were excluded the rate dropped to 17. The relation between the rate of measles infection and SSPE in Israel is shown in Figure 4 . The rates of SSPE for Israeli Jews and Arabs were compared to rates for Arabs living in Gaza and the west bank where measles immunization was not compulsory but available. The rates dropped steeply for both Israeli Jews and Arabs in 1977 with a significant delay in Gaza and the west bank. However, even in this particular population the decline in the number of new cases was dramatic to the point that no new cases were reported in both populations after 1986 ( Figure 5 ). Similar to data from other countries, the age of onset in Israeli patients increased parallel to the decrease in the rate of measles and SSPE, although in Arabs it remained around 10 years of age. (Figure 6 ). While new cases are a rarity today in counties with good measles control such as USA where the rate is very low (0.01/10 6 ), it is still quite high in counties with poor measles control (India; 21/10 6 , Japan; 11/10 6 , and Turkey; 0.461/10 6, (Gutierrez et al., 2010) . One of the highest rates of SSPE was found and is still present in Papua-New Guinea (PNG). This rate is only partially related to poor immunization control. During the years 1988-1999, a rate of 13-98/10 6 was found in individuals younger than 20 years of age. The rate of measles immunization in this particular population was stable at a level between 50-60 % of the population at risk during 1997-2008. A recent study from the referral hospital of the Madang Province in PNG mentioned a rate of 54/10 6 in individuals younger than 20 years, during 2007-2009. The rate was much higher in 4 sub-districts with an annual incidence of > 100/10 6 among the same age group. Those rates are the highest ever reported. The patients in this study contracted measles during their first year of life in 2002 and presented with SSPE 6-7 years later. A possible explanation for that very high rate in spite of a 60% rate of measles immunization in this region is the observation that only 36% of young Melanesian children respond well to measles vaccine and develop immunity to measles. (Manning et al., 2011) . From the above mentioned epidemiological data it is evident that SSPE is a "vanishing" disease in well developed countries while the disease is still taking the life of children in underdeveloped world regions. The variable incidence of SSPE can be explained not only in relation to the variability in measles morbidity, the degree of immunization coverage, the age of immunization, the different rates of virus mutations, male gender preponderance and ethnic origin, but it is also related to genetic polymorphism which determines the individual immune system reaction to measles vaccine as it happened in PNG. The different ethnic susceptibility to SSPE was studied in the multiethnic Israeli population. It was found that SSPE was more frequent among Sephardic than Ashkenazi Jews (3.4 vs. 0.5/10 6 , respectively) (Zilber et al., 1998) . 
Conclusion
SSPE can be added to the past pandemics such as small pox and poliomyelitis which were eradicated due to mass vaccination creating a world wide and an almost complete immunity to those devastating diseases. Although SSPE is not an acute infection "per se " like those mentioned above, this horrible disease was also eradicated due to mass immunization initiated when the "old" traditional methods of keen clinical judgment, basic epidemiology and the progress made by understanding the mechanisms involved in persistent viral infections made it clear that early infection with measles can cause SSPE. T h e r e i s s t i l l a n u r g e n t n e e d t o l o w e r t h e r a t e o f S S P E i n a r e a s w i t h p o o r m e a s l e s immunization coverage. Although we are at present unable to offer efficient treatment and cure to patients with a variety of degenerative progressive neurological disorders there are some hints to suggest that some of them might be the result of yet unknown "slow virus" infections.
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